GlassScriptPhysician profile
Alice Hong
NPI 1740431725
$7,767.32
in general payments reported to CMS, 2019-2025
62 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,719 · 2022: $1,027 · 2023: $2,267 · 2024: $1,582 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,021.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $806.56 | 2022-2025 | Excelsiusgps Robotic Navigation System, Creo, Excelsius Gps |
| Takeda Pharmaceuticals U.S.A., INC. | $543.73 | 2021-2025 | Ninlaro, Fruzaqla, Iclusig |
| Eisai INC. | $438.86 | 2021-2025 | |
| Janssen Biotech, INC. | $374.62 | 2021-2025 | Erleada, Rybrevant, Balversa |
| Medtronic, INC. | $335.10 | 2021-2023 | Cd Horizon Spinal System |
| Amgen INC. | $266.42 | 2021-2024 | Lumakras, Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $257.75 | 2022-2025 | Tagrisso, Lynparza, Calquence |
| Abbvie INC. | $255.66 | 2021-2025 | |
| Rigel Pharmaceuticals, INC. | $226.71 | 2021-2024 | Rezlidhia, Tavalisse |
| Bayer Healthcare Pharmaceuticals INC. | $218.75 | 2023-2024 | |
| Lilly USA, LLC | $203.81 | 2021-2024 | Jaypirca, Retevmo, Verzenio |
| Genzyme Corporation | $201.71 | 2021-2025 | |
| Gilead Sciences, INC. | $201.37 | 2021 | |
| Merck Sharp & Dohme LLC | $198.64 | 2021-2024 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $180.71 | 2023-2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $163.86 | 2021-2024 | |
| Emd Serono, INC. | $156.27 | 2022-2024 | Tepmetko, Bavencio |
| Stryker Corporation | $151.70 | 2023-2025 | Universal Neuro 3, Adherus Autospray Dural Sealant, Vsp System, Vsp Cranial |
| Seagen INC. | $147.48 | 2023 | Padcev, Tukysa |
| Glaxosmithkline, LLC. | $146.06 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Si-Bone, INC. | $141.39 | 2021-2025 | |
| Mirati Therapeutics, INC. | $140.27 | 2023-2024 | Krazati |
| Regeneron Healthcare Solutions, INC. | $115.84 | 2021-2023 | Libtayo |
| Recordati_rare_diseases_inc. | $114.55 | 2023-2025 | Sylvant |
| Deciphera Pharmaceuticals INC. | $113.38 | 2023-2024 | Qinlock |
| Daiichi Sankyo INC. | $105.52 | 2021-2024 | Enhertu |
| Intra-Sana Laboratories | $100.00 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $91.53 | 2023-2024 | Tazverik, Somatuline Depot, Onivyde |
| Incyte Corporation | $89.27 | 2021-2024 | Monjuvi, Pemazyre, Jakafi |
| Foundation Medicine, INC. | $81.38 | 2023 | |
| Dova Pharmaceuticals | $81.11 | 2021 | |
| Taiho Oncology, INC. | $76.35 | 2021-2024 | |
| Pfizer INC. | $73.46 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.49 | 2021-2022 | |
| Integra Lifesciences Corporation | $64.46 | 2025 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Stemline Therapeutics INC. | $62.69 | 2023-2024 | Orserdu |
| Sobi, INC | $62.64 | 2022-2023 | |
| Beone Medicines USA, INC. | $54.75 | 2025 | Brukinsa |
| Puma Biotechnology, INC. | $47.72 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $45.88 | 2023-2025 | Orgovyx |
| Agios Pharmaceuticals, INC. | $45.46 | 2024 | |
| Servier Pharmaceuticals LLC | $40.00 | 2022-2025 | |
| Pharmaessentia USA Corporation | $35.51 | 2023 | Besremi |
| Azurity Pharmaceuticals, INC. | $32.32 | 2025 | Danziten |
| Array Biopharma INC | $31.35 | 2021-2023 | Braftovi, Lorbrena |
| Ibsa Pharma INC. | $31.21 | 2021 | |
| Gt Medical Technologies, INC | $29.68 | 2022 | |
| Genmab U.S., INC. | $27.27 | 2024 | Epkinly |
| Beigene USA, INC. | $27.20 | 2025 | Brukinsa |
| Genentech USA, INC. | $25.00 | 2024 | Tecentriq |
| Pharmacyclics LLC, An Abbvie Company | $25.00 | 2021 | |
| Myovant Sciences INC. | $23.15 | 2022 | |
| Novocure INC. | $22.72 | 2025 | Optune Lua (Novottf-200t) |
| Boston Scientific Corporation | $21.99 | 2024 | Avvigo Guidance System |
| Eusa Pharma (US) LLC | $21.46 | 2021 | |
| Exelixis INC. | $20.00 | 2022 | |
| Pharmacosmos Therapeutics INC. | $18.33 | 2022 | |
| Opko Pharmaceuticals, LLC | $18.18 | 2021 | |
| Acrotech Biopharma INC. | $18.07 | 2021 | |
| Myriad Genetic Laboratories, INC. | $16.74 | 2023 | Myrisk |
| Clovis Oncology, INC. | $16.69 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.54 | 2023 | Seglentis, Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.